
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hilar lymphadenopathy
Introduction
Overview
Overview
Lymphadenopathy may be classified according to distribution into 2 groups localized lymphadenopathy and generalized lymphadenopathy.
Classification
Classification
Depending upon the involvement of the lymph nodes, lymphadenopathy is classified into 2 groups, generalized and localized:[1]
- Localized lymphadenopathy: localized adenopathy occurs in contiguous groupings of lymph nodes. In discrete anatomical regions, lymph nodes are distributed, and their enlargement represents their location’s lymphatic drainage. Tender or non-tender, fixed or mobile, and discreet or “matted” together can be the nodes themselves. 75 percent of all lymphadenopathies are localized, with over 50% seen in the region of the head and neck.
- Generalized lymphadenopathy: generalized lymphadenopathy involves lymphadenopathy in 2 or more non-contiguous sites. due to generalized infection all over the body e.g. influenza.
- Persistent generalized lymphadenopathy (PGL): persisting for a long time, possibly without an apparent cause.
- Dermatopathic lymphadenopathy: lymphadenopathy associated with skin disease. Tangier disease (ABCA1 deficiency) may also cause this.
Lymphadenopathy may be classified as follows:
- Location:
- Dermatopathic lymphadenopathy: lymphadenopathy associated with skin disease.
- Malignancy: Benign lymphadenopathy is distinguished from malignant types which mainly refer to lymphomas or lymph node metastasis.
- Extent:
- Localized lymphadenopathy: due to localized spot of infection
- Generalized lymphadenopathy: due to systemic infection of the body. In some cases, it may persist for prolonged periods possibly without an apparent cause
- Size, where lymphadenopathy in adults is often defined as a short axis of one or more lymph nodes is greater than 10mm.[2][3]
| Generally | 10Â mm[4][5] |
| Inguinal | 10[6] – 20 mm[7] |
| Pelvis | 10Â mm for ovoid lymph nodes, 8Â mm for rounded[6] |
| Neck | |
|---|---|
| Generally (non-retropharyngeal) | 10Â mm[6][8] |
| Jugulodigastric lymph nodes | 11mm[6] or 15Â mm[8] |
| Retropharyngeal | 8Â mm[8]
|
| Mediastinum | |
| Mediastinum, generally | 10Â mm[6] |
| Superior mediastinum and high paratracheal | 7mm[9] |
| Low paratracheal and subcarinal | 11Â mm[9] |
| Upper abdominal | |
| Retrocrural space | 6Â mm[10] |
| Paracardiac | 8Â mm[10] |
| Gastrohepatic ligament | 8Â mm[10] |
| Upper paraaortic region | 9Â mm[10] |
| Portacaval space | 10Â mm[10] |
| Porta hepatis | 7Â mm[10] |
| Lower paraaortic region | 11Â mm[10] |
References
References
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (2014). “Peripheral lymphadenopathy: approach and diagnostic tools”. Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Ganeshalingam S, Koh DM (December 2009). “Nodal staging”. Cancer Imaging. 9: 104–11. doi:10.1102/1470-7330.2009.0017. PMC 2821588. PMID 20080453.
- ↑ Schmidt AF, Rodrigues OR, Matheus RS, Kim Jdu U, Jatene FB (2007). “Mediastinal lymph node distribution, size and number: definitions based on an anatomical study”. J Bras Pneumol. 33 (2): 134–40. doi:10.1590/s1806-37132007000200006. PMID 17724531.
- ↑ Ganeshalingam, Skandadas; Koh, Dow-Mu (2009). “Nodal staging”. Cancer Imaging. 9 (1): 104–111. doi:10.1102/1470-7330.2009.0017. ISSN 1470-7330. PMC 2821588. PMID 20080453.
- ↑ Schmidt Júnior, Aurelino Fernandes; Rodrigues, Olavo Ribeiro; Matheus, Roberto Storte; Kim, Jorge Du Ub; Jatene, Fábio Biscegli (2007). “Distribuição, tamanho e número dos linfonodos mediastinais: definições por meio de estudo anatômico”. Jornal Brasileiro de Pneumologia. 33 (2): 134–140. doi:10.1590/S1806-37132007000200006. ISSN 1806-3713. PMID 17724531.
- ↑ 6.0 6.1 6.2 6.3 6.4 6.5 Torabi M, Aquino SL, Harisinghani MG (September 2004). “Current concepts in lymph node imaging”. Journal of Nuclear Medicine. 45 (9): 1509–18. PMID 15347718.
- ↑ “Assessment of lymphadenopathy”. BMJ Best Practice. Retrieved 2017-03-04. Last updated: Last updated: Feb 16, 2017
- ↑ 8.0 8.1 8.2 Page 432 in: Luca Saba (2016). Image Principles, Neck, and the Brain. CRC Press. ISBN 9781482216202.
- ↑ 9.0 9.1 Sharma, Amita; Fidias, Panos; Hayman, L. Anne; Loomis, Susanne L.; Taber, Katherine H.; Aquino, Suzanne L. (2004). “Patterns of Lymphadenopathy in Thoracic Malignancies”. RadioGraphics. 24 (2): 419–434. doi:10.1148/rg.242035075. ISSN 0271-5333. PMID 15026591.
- ↑ 10.0 10.1 10.2 10.3 10.4 10.5 10.6 Dorfman, R E; Alpern, M B; Gross, B H; Sandler, M A (1991). “Upper abdominal lymph nodes: criteria for normal size determined with CT”. Radiology. 180 (2): 319–322. doi:10.1148/radiology.180.2.2068292. ISSN 0033-8419. PMID 2068292.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2], Raviteja Guddeti, M.B.B.S. [3]Delband Yekta Moazami, M.D.[4] Ogechukwu Hannah Nnabude, MD
